GL1X · GenesisL1 explorer

Ligand · 1VO

1VO · 7-[5,6-dimethyl-2-(1,3-thiazol-4-yl)-1H-benzimidazol-1-yl]quinazoline-2,4-diamine

1VO, 7-[5,6-dimethyl-2-(1,3-thiazol-4-yl)-1H-benzimidazol-1-yl]quinazoline-2,4-diamine (C20 H17 N7 S, 387.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å…

Component
1VO
Formula
C20 H17 N7 S
Class
ligand
Structures
2
PDB entries
1

Binding sites

1VO in 2 structures; the first of them:

  • 4LAH · Structure-Based Design of New Dihydrofolate Reductase Antibacterial Agents… · 1VO X201 · binds LEU6, VAL7, ALA8, ASN19, GLN20, LEU21, ASP28, LEU29 and 9 more
  • 4LAH · Structure-based design of new dihydrofolate reductase antibacterial agents… · 1VO X201 · binds LEU6, VAL7, ALA8, ASN19, GLN20, LEU21, ASP28, LEU29 and 9 more

Residues it binds most

LEU 2, ILE 2, PHE 2, VAL 2, ALA 2, ASN 2, ASP 2, GLN 2, GLY 2, SER 2 (residue and the binding sites it lines).

Found with

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.